US Patent 7713960 Inhibition of the Raf/Mek/P-Erk pathway for treating cancer

Patent 7713960 was granted and assigned to University of South Florida on May, 2010 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Current Assignee

University of South Florida

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

7713960

Date of Patent

May 11, 2010

Patent Application Number

11490777

Date Filed

July 21, 2006

Patent Citations Received

‌

US Patent 11783366 Combination therapies

Patent Primary Examiner

‌

Frederick Krass

Patent abstract

The invention disclosed herein provides for methods of treating cancer using inhibitors of the Raf/Mek/P-Erk 1/2 pathway. These inhibitors include B2AR agonists (such as ARA-211 (pirbuterol) and isoproterenol), adenylyl cyclase activators, cAMP analogs and Epac activators. The invention also provides methods for diagnosing cancer in an individual.